Prof. Groves partner in consortium that receives H2020 Marie Curie ETN grant
Prof. Matthew Groves from the Groningen Research Institute of Pharmacy (GRIP) is partner in a consortium that has been awarded a H2020 Marie Curie ETN grant. The grant of EUR 3.2 million is for the MepAnti project, which aims to tackle the antimicrobial resistance problem by targeting enzymes of the methylerythritol phosphate pathway.
Antimicrobial resistance is a serious global health problem and, at present, there is no inter-institutional and interdisciplinary consortium explicitly focused on the discovery and development of novel anti-infective agents. The MepAnti consortium consists of nine academic partners and seven non-academic partners. The Helmholtz Institute for Pharmaceutical Research Saarland is coordinator. The consortium aims to go beyond the state-of-the-art in the anti-infective field by tackling the attractive and underexplored enzymes from the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway.
Prof. Groves receives EUR 265,000 for his part in the project. He will provide structural biology and biophysical expertise, with a focus on the first and rate-limiting step catalyzed by DXS.
Last modified: | 02 July 2020 09.12 a.m. |
More news
-
29 April 2024
Tactile sensors
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
29 April 2024
Behind the scenes: how UG and Hanze UAS students are jointly developing a Mars rover
This year the students of the Makercie team are participating in the physical edition of the European Rover Challenge in Poland. Read more about the team and the collaboration between the RUG and Hanze UAS here.
-
23 April 2024
Nine MSCA Doctoral Network grants for FSE researchers
Nine researchers of the Faculty of Science and Engineering have received a Horizon Europe Marie Sklodowska Curie Doctoral Network grant.